Ortek Therapeutics, Inc.
PrivateLast Round
Crowdfunding
Oct 13, 2022
Est. Valuation
$22.74M
Total Funding Raised
$4.41M
Company Overview
Ortek Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Roslyn Heights, New York. Its latest recorded funding round was a Crowdfunding round in October 2022.
Ortek Therapeutics, Inc. is a healthcare company that specializes in researching and commercializing oral care products and dental diagnostic technologies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ortek Therapeutics, Inc. Comparables
Compare Ortek Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quantum Dental Technologies Inc. | 84% | |
| AdDent, Inc. | 83% | |
| GreenMark Biomedical Inc. | 79% |
For institutional investors. Book with your work email.
Ortek Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Oct 13, 2022 | ||||
| Series B | Feb 28, 2003 | ||||
| Convertible Debt | May 8, 2002 | ||||
| Private Placement | Jul 9, 2001 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2022
$107K raised in a crowdfunding round.
- Feb 28, 2003
$2M round completed.
For institutional investors. Book with your work email.
Ortek Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ortek Therapeutics, Inc.'s valuation, stock price, and market status.
Is Ortek Therapeutics, Inc. a public or private company?
Ortek Therapeutics, Inc. is a private company.
What is the current stock price of Ortek Therapeutics, Inc.?
Ortek Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Ortek Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ortek Therapeutics, Inc. worth (valuation)?
Ortek Therapeutics, Inc.'s valuation is estimated at $22.7M based on funding round data.
Can I buy Ortek Therapeutics, Inc. stock?
Ortek Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ortek Therapeutics, Inc.'s last funding round?
Ortek Therapeutics, Inc.'s most recent funding round was Crowdfunding on October 13, 2022.
Who are the main investors in Ortek Therapeutics, Inc.?
Investor information for Ortek Therapeutics, Inc. is not publicly disclosed.
Will Ortek Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Ortek Therapeutics, Inc..
How can I track Ortek Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Ortek Therapeutics, Inc.'s shares on secondary markets.